Skip to main content
Signal8

Merrell Brendan W.

SEC insider (Form 3/4/5 filer). CIK 0002090383. CHIEF OPERATING OFFICER at OptimizeRx Corp (OPRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 21, 2026. Located in WALTHAM, MA.

Companies Merrell Brendan W. has filed insider reports for

  • OptimizeRx Corp (OPRX): Officer, CHIEF OPERATING OFFICER
Merrell Brendan W. profile photo

Merrell Brendan W.

CIK: 0002090383

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OptimizeRx Corp logo
OPRX

OptimizeRx Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Aug 21, 2026
    Tax Payment
    Direct
    1K shares at avg. $7.71$8K
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Aug 20, 2026
    Award
    Direct
    57.6K shares-
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Dec 19, 2025
    Tax Payment
    Direct
    289 shares at avg. $13.51$4K
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Dec 11, 2025
    Tax Payment
    Direct
    712 shares at avg. $14.03$10K
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Oct 3, 2025
    Tax Payment
    Direct
    483 shares at avg. $18.75$9K
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Aug 21, 2025
    Award
    Direct
    10.4K shares-

1-6 of 6